EUVIMEDEUVIMED entdecken
Crossref

A Vial Access Device for Facilitated Subcutaneous Immunoglobulin 10% Using Modular Innovation Principles and a Patient-Centric Design

Kimberly Duff, Stefan Holzner, Madeline Gibson, Seth Jones, Scott Ariagno

Infusion Journal · 2025

DOI: 10.70776/qhal9260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infusion Journal, 2025. Verfasst von Kimberly Duff und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Facilitated subcutaneous immunoglobulin 10% (fSCIG 10%) is packaged as a dual-vial unit of immunoglobulin G 10% (labelled ‘IG’) and recombinant human hyaluronidase (rHuPH20; labelled ‘HY’) for use as a prescribed immunoglobulin treatment for patients with primary or secondary immunodeficiency and chronic inflammatory demyelinating polyradiculoneuropathy. The current infusion process involves multiple steps that need repeating for patients requiring multiple dual-vial units per infusion. We hypothesized that the infusion process could be improved using patient-centric design and modular innovation principles.

Methods

Ethnographic research was conducted to understand patient and nurse experiences of administering fSCIG 10% to identify opportunities to improve the infusion process. Device design objectives were established based on feedback from 4 patients receiving fSCIG 10% for primary immunodeficiency (at-home observations and feedback sessions) and 4 nurses providing fSCIG 10% infusion training (interviews and mock training sessions). Design objectives included: simplifying steps for fSCIG 10% preparation and infusion, standardizing equipment and infusion stages and easing patient mobility during infusions. Formative usability evaluation research was conducted with 10 patients and 4 nurses to evaluate prototypes of a vial access device; observations were used to inform the modular design of the final device.

Results

The final vial access device is a base with numbered docking stations to accommodate up to 4 dual-vial units. Tubing underneath the docks separately combines the contents of multiple HY and IG vials, with separate color-coded connectors. The HY preparation process involves removing cover(s) from dock(s), inserting dual-vial units and drawing the total rHuPH20 dose into a single syringe from the HY connector attached to the device. To prepare IG, the pump tubing is attached to the IG connector on the device and primed. Following the delivery of HY, the pump tubing is attached to the same needle set; infusion administration remains similar to the current method. A device carrier, developed to hold the vial access device and a pump, enables patient mobility during the infusion. The vial access device is intended for single use and can be disposed of safely with the dual-vial units attached. Compared with the current fSCIG 10% infusion process, the vial access device simplified preparation, required fewer components and facilitated room-to- room patient mobility during infusion.

Conclusions

Patient-centric design and modular innovation principles were used to develop a vial access device to optimize the patient experience of fSCIG 10% infusion. Further research will assess its impact on patient quality of life.

Zitieren

APA

Duff, K., Holzner, S., Gibson, M., Jones, S., & Ariagno, S. (2025). A Vial Access Device for Facilitated Subcutaneous Immunoglobulin 10% Using Modular Innovation Principles and a Patient-Centric Design. Infusion Journal. https://doi.org/10.70776/qhal9260

Vancouver

Duff K, Holzner S, Gibson M, Jones S, Ariagno S. A Vial Access Device for Facilitated Subcutaneous Immunoglobulin 10% Using Modular Innovation Principles and a Patient-Centric Design. Infusion Journal. 2025. doi:10.70776/qhal9260

BibTeX
@article{Duff2025,
  author = {Duff, Kimberly and Holzner, Stefan and Gibson, Madeline and Jones, Seth and Ariagno, Scott},
  title = {A Vial Access Device for Facilitated Subcutaneous Immunoglobulin 10% Using Modular Innovation Principles and a Patient-Centric Design},
  journal = {Infusion Journal},
  year = {2025},
  doi = {10.70776/qhal9260}
}
Kostenlos starten →